CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 22 enrolled
Drug / intervention
Provant Therapy Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02696070
NCT02696070N/ACompleted
CompareCT.gov

A Multi-Center, Randomized, Sham-Controlled, Double-Blind Study of Pulsed Electromagnetic Field (PEMF) Therapy to Evaluate Small Fiber Nerve Growth and Function in Subjects With Painful Peripheral Diabetic Neuropathy

Regenesis Biomedical, Inc.·interventional·Posted Mar 2, 2016·Updated Jan 12, 2018

In Brief

A clinical study evaluating Provant Therapy System for Painful Peripheral Diabetic Neuropathy. Completed, enrolled 22 participants across 1 site.

Detailed Summary

This study is designed to evaluate the effectiveness of the Provant Therapy System in improving localized nerve growth and skin perfusion in subjects with painful peripheral diabetic neuropathy of the foot.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPainful Peripheral Diabetic Neuropathy
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedMar 2, 2016
Enrollment StartJul 1, 2015
Primary CompletionDec 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 10.3 years ago

Interventions

Provant Therapy Systemdevice